Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy

Bone Marrow Transplantation volume 53, pages 960–966 (2018)Cite this article

Subjects

Abstract

Autologous stem cell transplantation (auto-HSCT) is an effective treatment strategy for hematological malignancies. The standard mode of handling hematopoietic progenitors for the autologous procedure (CRYO) consists on its collection and freezing with dimethyl sulfoxide (DMSO) and its subsequent thawing and re-infusion. This process is toxic and expensive. Non-cryopreserved (non-CRYO) is a less expensive mode of auto-HSCT. We designed a comparative study between both strategies performed in two different centers to analyze the short-term complications. In total 111 auto-HSCT were performed from January/2015 to October/2016 (42 non-CRYO and 74 CRYO). There were 74 males and 69 (62%) patients had the underlying diagnosis of multiple myeloma. No differences were seen on the characteristics of the apheresis products and their viability. Engraftment was significantly faster in the non-CRYO group (p = 0.001). Febrile neutropenia and severe mucositis were lower in the non-CRYO group (40% vs 92% p = 0.0001 and 11% vs 64%, p = 0.001, respectively). In addition, length of hospitalization was 5 days shorter in the non-CRYO group (p = 0.0001). Overall responses and transplantation outcomes were similar. Our data demonstrate a clear advantage of the non-CRYO over CRYO auto-HSCT with faster engraftment, lower incidence of febrile neutropenia and shorter hospital stay after the transplantation procedure. These data are especially relevant for centers with high transplant activity or with limited resources.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Naumann-Winter F, Greb A, Borchmann P, Bohlius J, Engert A, Schnell R. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Cochrane Database Syst Rev. 2012;10:CD004626.

    PubMed  Google Scholar 

  2. Sibon D, Morschhauser F, Resche-Rigon M, Ghez D, Dupuis J, Marçais A, et al. Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group. Haematologica. 2016;101:474–81.

    Article  Google Scholar 

  3. Bakken AM. Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther. 2006;1:47–54.

    Article  CAS  Google Scholar 

  4. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood. 1988;71:723–7.

    CAS  PubMed  Google Scholar 

  5. Zenhäusern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79:523–6.

    Article  Google Scholar 

  6. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant. 2000;25:1299–301.

    Article  CAS  Google Scholar 

  7. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant. 2000;25:1285–7.

    Article  CAS  Google Scholar 

  8. Morris C, de Wreede L, Scholten M, Brand R, van Biezen A, Sureda A, et al. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion. 2014;54:2514–22.

    Article  CAS  Google Scholar 

  9. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Glück S. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant. 2004;10:135–41.

    Article  CAS  Google Scholar 

  10. Stiff PJ, Dahlberg S, Forman SJ, McCall AR, Horning SJ, Nademanee AP, et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin’s lymphoma: value of augmented preparative regimens–a Southwest Oncology Group trial. J Clin Oncol. 1998;16:48–55.

    Article  CAS  Google Scholar 

  11. Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, et al. Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Transfusion. 2011;51:2175–82.

    Article  Google Scholar 

  12. Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transpl. 1996;17:425–30.

    CAS  Google Scholar 

  13. Cox MA, Kastrup J, Hrubisko M. Historical perspectives and the future of adverse reactions associeated with haematopoietic stem cells cryopreserved with dimtethyl sulfoxide. Cell Tissue Bank. 2012;13:203–15.

    Article  CAS  Google Scholar 

  14. Ager S, Scott MA, Mahendra P, Richards EM, Jestice HK, Boraks P, et al. Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant. 1995;16:79–83.

    CAS  PubMed  Google Scholar 

  15. Naithani R, Rai R. Non-cryopreserved storage is feasible for autologous stem cell transplantation in multiple myeloma previously treated with melphalan. Clin Transplant. 2012;26:E449.

    Article  Google Scholar 

  16. Ahmed T, Wuest D, Ciavarella D, Ayello J, Feldman EJ, Biguzzi S,D, et al. Marrow storage techniques: a clinical comparison of refrigeration versus cryopreservation. Acta Haematol. 1991;85:173–8.

    Article  CAS  Google Scholar 

  17. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, et al. International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 2006;20:1467–73.

    Article  CAS  Google Scholar 

  18. Cheeson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.

    Article  Google Scholar 

  19. Ruiz-Argüelles G, Gomez-Rangela D, Ruiz-Delgado G, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L. Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience. Acta Haematol. 2003;110:179–83.

    Article  Google Scholar 

  20. Mabed M, Shamaa S. High-dose chemotherapy plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed hodgkin disease. Biol Blood Marrow Transpl. 2006;12:942–8.

    Article  CAS  Google Scholar 

  21. Papadimitriou CA, Dimopoulos MA, Kouvelis V, Kostis E, Kapsimali V, Contoyannis D, et al. Non-cryopreserved peripheral blood progenitor cells collected by a single very large-volume leukapheresis: a simplified and effective procedure for support of high-dose chemotherapy. J Clin Apher. 2000;15:236–41.

    Article  CAS  Google Scholar 

  22. Cuellar-Ambrosi F, Karduss UA, Gomez WR, Mondragon MC, Velasquez-Lopera M, Calles S, et al. Hematologic reconstitution following high-dose and supralethal chemoradiotherapy using stored, noncryopreserved autologous hematopoietic stem cells. Transplant Proc. 2004;36:1704–5.

    Article  CAS  Google Scholar 

  23. Holowiecki J, Giebel S, Wojnar J, Krawczyk-Kulis M, Stella-Holowiecka B, Kachel L, et al. Autologous hematopoietic stem cell transplantation for high-risk Hodgkin’s disease: a single-center experience with the first 100 patients. Transplant Proc. 2002;34:3378–83.

    Article  CAS  Google Scholar 

  24. Sierra J, Conde E, Iriondo A, Brunet S, Marin J, Pérez de Oteiza J, et al. Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group. Ann Hematol. 1993;67:111–4.

    Article  CAS  Google Scholar 

  25. Kayal S, Sharma A, Iqbal S, Tejomurtula T, Cyriac S, Raina V. High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma: a single institution experience at All India Institute of Medical Sciences, New Delhi, using non-cryopreserved peripheral blood stem cells. Lymphoma Myeloma Leuk. 2014;14:140–7.

    Article  Google Scholar 

  26. Wannesson L, Panzarella T, Mikhael J, Keating A. Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review. Ann Oncol. 2007;18:623–32.

    Article  CAS  Google Scholar 

  27. Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma. Bone Marrow Transplant. 2004;34:581–7.

    Article  CAS  Google Scholar 

  28. Köpler H, Pfluger KH, Havemann K. Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue. Ann Hematol. 1991;63:253–8.

    Article  Google Scholar 

  29. Carella AM, Santini G, Giordano D, Frassoni F, Nati S, Congiu A, et al. High-dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy. Cancer. 1984;54:2836–9.

    Article  CAS  Google Scholar 

  30. Lisenko K, Pavel P, Kriegsmann M, Bruckner T, Hillengass J, Goldschmidt H, et al. Storage duration of autologous stem cell preparations has no impact on hematopoietic recovery after transplantation. Biol Blood Marrow Transplant. 2016;23:684–90.

    Article  Google Scholar 

  31. Parody R, Caballero D, Márquez-Malaver FJ, Vázquez L, Saldaña R, Madrigal MD, et al. To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors. Eur J Haematol. 2013;91:448–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Programa de Trasplante Hematopoyético del Adulto, Pontificia Universidad Católica de Chile, Santiago, Chile

    M. Sarmiento, P. Ramírez, N. Beffermann, V. Jara, P. Bertín, I. Pizarro, C. Lorca, E. Rivera, M. Galleguillos & M. Ocqueteau

  2. Clinical Hematology Department, Institut Català d’Oncologia, Hospital Duran i Reynals, Barcelona, Spain

    R. Parody, MQ. Salas, I. Sánchez-Ortega, B. Patiño & A. Sureda

Authors
  1. M. Sarmiento
    View author publications

    Search author on:PubMed Google Scholar

  2. P. Ramírez
    View author publications

    Search author on:PubMed Google Scholar

  3. R. Parody
    View author publications

    Search author on:PubMed Google Scholar

  4. MQ. Salas
    View author publications

    Search author on:PubMed Google Scholar

  5. N. Beffermann
    View author publications

    Search author on:PubMed Google Scholar

  6. V. Jara
    View author publications

    Search author on:PubMed Google Scholar

  7. P. Bertín
    View author publications

    Search author on:PubMed Google Scholar

  8. I. Pizarro
    View author publications

    Search author on:PubMed Google Scholar

  9. C. Lorca
    View author publications

    Search author on:PubMed Google Scholar

  10. E. Rivera
    View author publications

    Search author on:PubMed Google Scholar

  11. M. Galleguillos
    View author publications

    Search author on:PubMed Google Scholar

  12. M. Ocqueteau
    View author publications

    Search author on:PubMed Google Scholar

  13. I. Sánchez-Ortega
    View author publications

    Search author on:PubMed Google Scholar

  14. B. Patiño
    View author publications

    Search author on:PubMed Google Scholar

  15. A. Sureda
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to M. Sarmiento.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarmiento, M., Ramírez, P., Parody, R. et al. Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy. Bone Marrow Transplant 53, 960–966 (2018). https://doi.org/10.1038/s41409-018-0117-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41409-018-0117-5

This article is cited by

Search

Advanced search

Quick links